rs121908072
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_138691.3(TMC1):c.1714G>A(p.Asp572Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D572H) has been classified as Pathogenic.
Frequency
Consequence
NM_138691.3 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 7Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: SD, AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen
- autosomal dominant nonsyndromic hearing loss 36Inheritance: AD, AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD4 exome Cov.: 31 
GnomAD4 genome  
ClinVar
Submissions by phenotype
Autosomal dominant nonsyndromic hearing loss 36    Pathogenic:3 
- -
- -
- -
not provided    Pathogenic:2 
The TMC1 c.1714G>A; p.Asp572Asn variant (rs121908072) is reported in the literature segregating with disease in several families affected with autosomal dominant hearing loss (Hilgert 2009, Kurima 2002, Wang 2018, Wei 2014). This variant is reported in ClinVar (Variation ID: 4102), but is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. Additionally, another variant at this codon (c.1714G>C; p.Asp572His) has been reported in a large family affected with autosomal dominant hearing loss (Kitajiri 2007). Based on available information, this variant is considered to be pathogenic. References: Hilgert N et al. Amino acid 572 in TMC1: hot spot or critical functional residue for dominant mutations causing hearing impairment. J Hum Genet. 2009;54(3):188-190. Kitajiri S et al. A novel mutation at the DFNA36 hearing loss locus reveals a critical function and potential genotype-phenotype correlation for amino acid-572 of TMC1. Clin Genet. 2007;71(2):148-152. Kurima et al. Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function. Nat Genet. 2002 Mar;30(3):277-84. Wang et al. Identification of four TMC1 variations in different Chinese families with hereditary hearing loss. Mol Genet Genomic Med. 2018 Apr 14. Wei Q et al. Targeted genomic capture and massively parallel sequencing to identify novel variants causing Chinese hereditary hearing loss. J Transl Med. 2014;12:311. Published 2014 Nov 12. -
Published functional studies demonstrate a damaging effect: severe disruption of LHFPL5 binding (Yu et al., 2020); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 17250663, 15354000, 25388789, 26226225, 26079994, 29654653, 31854501, 31541171, 19180119, 11850618, 33168709, 27535533) -
Rare genetic deafness    Pathogenic:1 
The p.Asp572Asn in TMC1 has been previously reported in 3 probands with nonsyndr omic bilateral sensorineural hearing loss, and segregated with disease in a domi nant pattern in >10 affected family members (Kurima 2002, Hilgert 2009, Makishim a 2004, Wei 2014). The hearing loss was reported to be progressive with a postli ngual onset. The variant was identified in one unaffected individual from one fa mily, indicating that the penetrance may not be complete; however the age of thi s individual was also not reported (Hilgert 2009). This variant was absent from large population databases. A variant affecting the same amino acid (p.Asp572His ) has also been reported in an individual with hearing loss and segregated in 7 affected family members including 2 obligate carriers (Kitajiri 2007), further s upporting that missense variants at this position are not tolerated. Unlike loss of function variants in TMC1, which cause recessive hearing loss, these studies indicate that the p.Asp572Asn and p.Asp572His missense variants cause dominant hearing loss. In summary, the p.Asp572Asn variant meets our criteria to be class ified as pathogenic for autosomal dominant sensorineural hearing loss (http://ww w.partners.org/personalizedmedicine/LMM) based upon segregation studies in affec ted families and its absence in the general population. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at